Planning Benchmark Study for Stereotactic Body Radiation Therapy of Liver Metastases: Results of the DEGRO/DGMP Working Group on Stereotactic Radiation Therapy and Radiosurgery.

Benchmarking Humans Liver Neoplasms / diagnostic imaging Radiosurgery / methods Radiotherapy Dosage Radiotherapy Planning, Computer-Assisted / methods Radiotherapy, Intensity-Modulated / methods

Journal

International journal of radiation oncology, biology, physics
ISSN: 1879-355X
Titre abrégé: Int J Radiat Oncol Biol Phys
Pays: United States
ID NLM: 7603616

Informations de publication

Date de publication:
01 05 2022
Historique:
received: 26 06 2021
revised: 19 12 2021
accepted: 07 01 2022
pubmed: 26 1 2022
medline: 20 4 2022
entrez: 25 1 2022
Statut: ppublish

Résumé

Our purpose was to investigate whether liver stereotactic body radiation therapy treatment planning can be harmonized across different treatment planning systems, delivery techniques, and institutions by using a specific prescription method and to minimize the knowledge gap concerning intersystem and interuser differences. We provide best practice guidelines for all used techniques. A multiparametric specification of target dose (gross target volume [GTV] GTV This study showed the feasibility of harmonizing liver stereotactic body radiation therapy treatment plans across different treatment planning systems and delivery techniques when a sufficient set of clinical goals is given.

Identifiants

DOI: 10.1016/j.ijrobp.2022.01.008 PMID: 35074434
pubmed: 35074434
pii: S0360-3016(22)00018-9
doi: 10.1016/j.ijrobp.2022.01.008
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

214-227

Informations de copyright

Copyright © 2022 Elsevier Inc. All rights reserved.

Auteurs

Christos Moustakis (C)

Department of Radiation Oncology, University Hospital Muenster, Muenster, Germany. Electronic address: christos.moustakis@ukmuenster.de.

Oliver Blanck (O)

Department of Radiation Oncology, University Medical Center Schleswig Holstein, Kiel, Germany; Saphir Radiosurgery Center, Frankfurt and Northern Germany, Kiel, Germany.

Mark Ka Heng Chan (MKH)

Department of Radiation Oncology, University Medical Center Schleswig Holstein, Kiel, Germany.

Judit Boda-Heggemann (J)

Department of Radiation Oncology, University Medicine Mannheim, Medical Faculty Mannheim, University Heidelberg, Mannheim, Germany.

Nicolaus Andratschke (N)

Department of Radiation Oncology, University Hospital Zurich, University of Zurich, Zurich, Switzerland.

Marciana-Nona Duma (MN)

Department of Radiation Oncology, University Hospital Rechts der Isar, Technical University, Munich, Germany; Department of Radiation Oncology, University Hospital Jena, Jena, Germany.

Dirk Albers (D)

Department of Radiotherapy and Radiation Oncology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.

Christian Bäumer (C)

West German Proton Therapy Centre, Essen, Germany.

Roman Fehr (R)

Department of Radiation Oncology, University Medicine Rostock, Rostock, Germany.

Stefan A Körber (SA)

Department of Radiation Oncology, Heidelberg University Hospital, Heidelberg, Germany.

Daniel Schmidhalter (D)

Division of Medical Radiation Physics and Department of Radiation Oncology, Inselspital, Bern University Hospital, and University of Bern, Bern, Switzerland.

Manfred Alraun (M)

Department of Radiation Oncology, Schwarzwald-Baar Hospital, Villingen-Schwenningen, Germany.

Wolfgang W Baus (WW)

Department of Radiation Oncology, University Hospital Cologne, Cologne, Germany.

Eric Beckers (E)

Gamma Knife Center Krefeld, Krefeld, Germany.

Mathias Dierl (M)

Department of Radiation Oncology, Hospital Bayreuth, Bayreuth, Germany.

Stephan Droege (S)

Department of Radiation Oncology, Lung Clinic Hemer, Hemer, Germany.

Fatemeh Ebrahimi Tazehmahalleh (F)

Department of Radiation Oncology, University Hospital Muenster, Muenster, Germany; Department of Radiation Oncology, University Hospital Cologne, Cologne, Germany.

Jens Fleckenstein (J)

Department of Radiation Oncology, University Medicine Mannheim, Medical Faculty Mannheim, University Heidelberg, Mannheim, Germany.

Matthias Guckenberger (M)

Department of Radiation Oncology, University Hospital Zurich, University of Zurich, Zurich, Switzerland.

Christian Heinz (C)

Department of Radiation Oncology, University Hospital Munich, LMU Munich, Munich, Germany.

Christoph Henkenberens (C)

Department of Radiation Oncology, Medical University Hannover, Hannover, Germany.

Andreas Hennig (A)

Private Practice for Radiation Oncology, Distler Bautzen, Germany.

Janett Köhn (J)

Saphir Radiosurgery Center, Frankfurt and Northern Germany, Kiel, Germany; Department of Radiation Oncology, University Hospital Frankfurt, Frankfurt, Germany.

Christine Kornhuber (C)

Department of Radiation Oncology, University Hospital Halle, Halle (Saale), Germany.

Thomas Krieger (T)

Department of Radiation Oncology, University Hospital Wuerzburg, Wuerzburg, Germany.

Britta Loutfi-Krauss (B)

Saphir Radiosurgery Center, Frankfurt and Northern Germany, Kiel, Germany; Department of Radiation Oncology, University Hospital Frankfurt, Frankfurt, Germany.

Manfred Mayr (M)

Private Practice for Radiation Oncology South, Kaufbeuren, Germany.

Markus Oechsner (M)

Department of Radiation Oncology, University Hospital Rechts der Isar, Technical University, Munich, Germany.

Tina Pfeiler (T)

West German Proton Therapy Centre, Essen, Germany.

Gerhard Pollul (G)

Department of Radiation Oncology, University Hospital Mainz, Mainz, Germany.

Jürgen Schöffler (J)

Private Practice for Radiation Oncology, Boeblingen, Germany.

Heiko Tümmler (H)

Private Practice for Radiation Oncology, Dresden, Germany.

Claudia Ullm (C)

Radiologie Muenchen, Private Practice for Radiation Oncology, Munich, Germany.

Mathias Walke (M)

Department of Radiation Oncology, University Hospital Magdeburg, Magdeburg, Germany.

Rocco Weigel (R)

Department of Radiation Oncology, University Hospital Innsbruck, Innsbruck, Austria.

Martin Wertman (M)

Department of Radiation Oncology, University Medicine Rostock, Rostock, Germany; Department of Radiation Oncology, Ernst von Bergmann Hospital, Potsdam, Germany.

Rolf Wiehle (R)

Department of Radiation Oncology, University Hospital Freiburg, Freiburg, Germany.

Tilo Wiezorek (T)

Department of Radiation Oncology, University Hospital Jena, Jena, Germany.

Lotte Wilke (L)

Department of Radiation Oncology, University Hospital Zurich, University of Zurich, Zurich, Switzerland.

Ulrich Wolf (U)

Department of Radiation Oncology, University Hospital Leipzig, Leipzig, Germany.

Hans Theodor Eich (HT)

Department of Radiation Oncology, University Hospital Muenster, Muenster, Germany.

Daniela Schmitt (D)

Department of Radiation Oncology, Heidelberg University Hospital, Heidelberg, Germany; Department of Radiation Oncology, University Medical Center Goettingen, Goettingen, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female

Evaluation of Low-Value Services Across Major Medicare Advantage Insurers and Traditional Medicare.

Ciara Duggan, Adam L Beckman, Ishani Ganguli et al.
1.00
Humans United States Aged Cross-Sectional Studies Medicare Part C

Effectiveness of Virtual Yoga for Chronic Low Back Pain: A Randomized Clinical Trial.

Hallie Tankha, Devyn Gaskins, Amanda Shallcross et al.
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH

questionsmedicales.fr › Qualité, accès, évaluation des soins de santé › Qualité des soins de santé › Mécanismes d'évaluation des soins de santé › Évaluation de programme › Référenciation › Planning Benchmark Study for Stereotactic Body...
questionsmedicales.fr › Eucaryotes › Animaux › Chordés › Vertébrés › Mammifères › Eutheria › Primates › Haplorhini › Catarrhini › Hominidae › Humains › Planning Benchmark Study for Stereotactic Body...
questionsmedicales.fr › Maladies de l'appareil digestif › Maladies du foie › Tumeurs du foie › Planning Benchmark Study for Stereotactic Body...
questionsmedicales.fr › Techniques d'investigation › Techniques stéréotaxiques › Radiochirurgie › Planning Benchmark Study for Stereotactic Body...
questionsmedicales.fr › Thérapeutique › Radiothérapie › Dosimétrie en radiothérapie › Planning Benchmark Study for Stereotactic Body...
questionsmedicales.fr › Sciences de l'information › Informatique › Informatique médicale › Applications de l'informatique médicale › Prise de décision assistée par ordinateur › Thérapie assistée par ordinateur › Radiothérapie assistée par ordinateur › Planification de radiothérapie assistée par ordinateur › Planning Benchmark Study for Stereotactic Body...
questionsmedicales.fr › Sciences de l'information › Informatique › Informatique médicale › Applications de l'informatique médicale › Prise de décision assistée par ordinateur › Thérapie assistée par ordinateur › Radiothérapie assistée par ordinateur › Radiothérapie conformationnelle › Radiothérapie conformationnelle avec modulation d'intensité › Planning Benchmark Study for Stereotactic Body...